SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi Consumer Healthcare India reports over two-fold jump in Q2 net profit

05 Aug 2025 Evaluate

Sanofi Consumer Healthcare India has reported result for second quarter ended June 30, 2025. 

The company has reported over two-fold jump in its net profit at Rs 60.70 crore for the quarter ended June 30, 2025 as compared to Rs 29 crore for the same quarter in the previous year. The total income of the company increased by 30.85% at Rs 226.50 crore for the quarter ended June 30, 2025 as compared to Rs 173.10 crore for the corresponding quarter previous year.

Sanofi Consumer Healthcare India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.


Sanofi Cons. Health Share Price

4723.05 -49.95 (-1.05%)
11-May-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.00
Dr. Reddys Lab 1281.55
Cipla 1339.50
Zydus Lifesciences 932.80
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×